THERMO FISHER SCIENTIFIC INC. 4

Marc N. Casper, Chairman & CEO of Thermo Fisher Scientific Inc. (TMO), exercised 10,000 options and sold about 14,111 shares of common stock (directly and via Floral Park Associates, Inc.) in multiple Rule 10b5‑1 trades around the mid‑$560s to high‑$570s on August 5, 2026.

On August 5, 2026, Thermo Fisher Scientific Inc. Chairman & CEO Marc N. Casper exercised 10,000 stock options with a strike price of $309.63, acquiring 10,000 shares of TMO common stock, and concurrently executed a series of pre‑planned Rule 10b5‑1 sales in multiple tranches both from his direct holdings and from an indirectly held account (Floral Park Associates, Inc.) at weighted average prices generally in the mid‑$560s to high‑$570s. The direct sales totaled 9,100 shares (157 + 130 + 105 + 53 + 135 + 431 + 1,186 + 2,223 + 2,930 + 2,575 + 75) for roughly $5.2 million in proceeds, while the indirect Floral Park sales totaled 5,011 shares (79 + 66 + 38 + 40 + 68 + 216 + 590 + 1,113 + 1,464 + 1,289 + 37) for roughly $2.9 million. After these transactions, Casper beneficially owned approximately 133,925.358 shares directly (with additional indirect holdings through Floral Park), with an estimated direct position value of about $79.3 million based on a recent market price near $592 per share, and the filing notes that this Form 4 is one of two covering trades on August 5 and 6, 2026 that could not be consolidated due to SEC line‑item limits.

Filing Facts

CIK

97745

Ticker

TMO

Form

4

Source Type

sec

Accession

0001216055-26-000006

Alert Tier

7